Brandon Smith
Partner at Childers, Schlueter & Smith, LLC
I’m M. Brandon Smith, a partner at Childers, Schlueter & Smith in Atlanta, Georgia, helping injured people nationwide with pharmaceutical litigation, mass torts, product liability, and serious personal injury cases.
Posts
-
New Study Examines Antiseizure Drugs Linked to Stevens-Johnson Syndrome and TEN
New research identifies the antiseizure drugs most often associated with SJS and TEN and explores why determining which medication triggered a reaction can be complicated.
-
First Federal Mead Johnson NEC Bellwether Ends in Defense Verdict as Litigation Continues
The first federal Mead Johnson NEC baby formula bellwether ended in a defense verdict, but hundreds of federal lawsuits remain pending as the litigation continues.
-
Abbott Reaches $670 Million NEC Baby Formula Settlement as Thousands of Claims Continue
Abbott’s agreement resolves thousands of claims, but NEC baby formula litigation continues nationwide. Here’s what families with potential claims should know.
-
Why the First Federal Mead Johnson NEC Baby Formula Trial Is Significant
A Mead Johnson case involving Enfamil Premature is reaching a federal jury, marking a new stage in the nationwide NEC baby formula litigation.
-
Two New Appeals Court Decisions Show NEC Baby Formula Litigation Is Far From Over
Two recent appellate decisions reached different outcomes in NEC baby formula litigation, highlighting how appeals continue to shape lawsuits involving Abbott, Mead Johnson, and claims that cow's milk-based formula increased the risk of necrotizing enterocolitis in premature infants.
-
Why Clark v. Leigh May Be One of Georgia's Most Important Medical Malpractice Decisions in Years
A new Georgia Supreme Court decision could influence medical malpractice and wrongful death litigation for years by reaffirming important jury trial protections and limiting how damages caps apply.
-
FDA Expands Dupixent Use as Questions About Rare Lymphoma Continue
The FDA has expanded Dupixent's use to additional pediatric patients while continuing to review reports of cutaneous T-cell lymphoma. Researchers, regulators, and attorneys are closely watching developments involving the widely prescribed medication.
-
Missouri Appeals Court Upholds $495 Million Verdict in Abbott NEC Baby Formula Lawsuit
The appellate ruling rejected key defense arguments from Abbott Laboratories and could influence future NEC baby formula lawsuits involving premature infants and cow’s milk-based formula products.
-
Illinois NEC Baby Formula Trial Ends in $70M Jury Award
A recent Illinois NEC baby formula verdict is adding to ongoing litigation involving claims that certain preterm formulas increased the risk of NEC in premature infants.
-
MDL 3026 Preterm Infant Formula Litigation Lands in Northern District of Illinois
We are pleased to report that the United States Judicial Panel on Multidistrict Litigation (JPML) has now created and assigned MDL 3026
Subscribe to Brandon Smith
Get new posts delivered to your inbox.